Who owns Verrica Pharmaceuticals Inc?
- Ticker: VRCA
- CUSIP Number: 92511w108
Tip: Access positions for across all investors
Analyze quarterly positions in Verrica Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Verrica Pharmaceuticals stock
Who bought or sold Verrica Pharmaceuticals Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Perceptive Advisors | 7.1M | $42M | 0% | Mar 2024 |
|
| venBio Select Advisor | 4.0M | $29M | 35% | Dec 2023 |
|
| FMR | 1.5M | $8.9M | 0% | Mar 2024 |
|
| Vanguard Group | 1.3M | $7.5M | 1% | Mar 2024 |
|
| BlackRock | 1.1M | $6.6M | 6% | Mar 2024 |
|
| Geode Capital Management | 449k | $2.7M | 8% | Mar 2024 |
|
| Northern Trust | 199k | $1.2M | 6% | Mar 2024 |
|
| Deutsche Bank Aktiengesellschaft | 184k | $1.1M | 115% | Mar 2024 |
|
| BML Capital Management | 180k | $1.1M | 0% | Mar 2024 |
|
| Steel Peak Wealth Management | 138k | $817k | 0% | Mar 2024 |
|
| Morgan Stanley | 134k | $795k | 13% | Mar 2024 |
|
| Miracle Mile Advisors | 118k | $700k | 0% | Mar 2024 |
|
| Nuveen Asset Management | 95k | $563k | 0% | Mar 2024 |
|
| Bridgeway Capital Management | 82k | $487k | 10% | Mar 2024 |
|
| Kornitzer Capital Management | 74k | $440k | 0% | Mar 2024 |
|
| Charles Schwab Investment Management | 55k | $328k | 0% | Mar 2024 |
|
| Bank of New York Mellon | 54k | $321k | -3% | Mar 2024 |
|
| Kovitz Investment Group Partners | 50k | $297k | 0% | Mar 2024 |
|
| SPC Financial | 30k | $178k | 0% | Mar 2024 |
|
| J. Goldman & Co | 27k | $160k | -75% | Mar 2024 |
|
| Bank of America Corporation | 27k | $160k | -26% | Mar 2024 |
|
| Two Sigma Investments | 25k | $149k | 100% | Mar 2024 |
|
| UBS Group | 22k | $132k | -8% | Mar 2024 |
|
| Rhumbline Advisers | 22k | $131k | -1% | Mar 2024 |
|
| Stifel Financial | 21k | $121k | 0% | Mar 2024 |
|
| Goldman Sachs Group | 20k | $116k | 100% | Mar 2024 |
|
| Creative Planning | 19k | $113k | 0% | Mar 2024 |
|
| Legacy Trust | 19k | $111k | 0% | Mar 2024 |
|
| Mariner Wealth Advisors | 18k | $104k | 100% | Mar 2024 |
|
| Barclays | 15k | $86k | -49% | Mar 2024 |
|
| Dimensional Fund Advisors | 12k | $69k | 0% | Mar 2024 |
|
| Cambridge Investment Research Advisors | 12k | $68k | 100% | Mar 2024 |
|
| Branch Banking & Trust Company | 11k | $62k | 0% | Mar 2024 |
|
| American International | 10k | $76k | 0% | Dec 2023 |
|
| Bnp Paribas Arbitrage, Snc | 10k | $61k | -74% | Mar 2024 |
|
| New York State Common Retirement Fund | 9.8k | $58k | 8% | Mar 2024 |
|
| Jpmorgan Chase & Co | 8.7k | $52k | -36% | Mar 2024 |
|
| Wells Fargo & Company | 7.7k | $46k | -22% | Mar 2024 |
|
| Spire Wealth Management | 5.7k | $33k | 0% | Mar 2024 |
|
| Citigroup | 3.8k | $23k | 28% | Mar 2024 |
|
| Salomon & Ludwin | 2.9k | $17k | 0% | Mar 2024 |
|
| Legal & General Group | 2.5k | $15k | 0% | Mar 2024 |
|
| Royal Bank of Canada | 2.5k | $16k | -72% | Mar 2024 |
|
| Simplex Trading | 2.3k | $13k | -49% | Mar 2024 |
|
| California State Teachers Retirement System | 2.1k | $12k | -54% | Mar 2024 |
|
| Summit Investment Advisors | 1.7k | $10k | 0% | Mar 2024 |
|
| Tower Research Capital | 1.5k | $9.0k | -60% | Mar 2024 |
|
| Cetera Trust Company | 1.0k | $5.9k | 0% | Mar 2024 |
|
| Amalgamated Bank | 704.00 | $4.0k | -76% | Mar 2024 |
|
| Group One Trading | 698.00 | $4.1k | -95% | Mar 2024 |
|
| Old Point Trust & Financial Services N A | 500.00 | $3.0k | 100% | Mar 2024 |
|
| Pnc Financial Services | 222.00 | $1.3k | 1750% | Mar 2024 |
|
| Coppell Advisory Solutions | 200.00 | $1.5k | 0% | Dec 2023 |
|
| Advisor Group Holdings | 100.00 | $592.000000 | 0% | Mar 2024 |
|
| Russell Investments | 71.00 | $420.000500 | 0% | Mar 2024 |
|
| Farther Finance Advisors | 22.00 | $130.000200 | 100% | Mar 2024 |
|
| Carmichael Hill & Associates | 21.00 | $125.000400 | 0% | Mar 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 4.00 | $23.000000 | 100% | Mar 2024 |
|
| CWM | 3.00 | $0 | 100% | Mar 2024 |
|
Who sold out of Verrica Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Balyasny Asset Management | Dec 2023 | 65k | $478k |
| Mirae Asset Global Investments | Dec 2023 | 48k | $351k |
| GSA Capital Partners | Dec 2023 | 39k | $282k |
| LPL Financial | Sep 2023 | 36k | $140k |
| AQR Capital Management | Dec 2023 | 22k | $164k |
| Citadel Advisors | Dec 2023 | 19k | $138k |
| Jump Financial | Sep 2023 | 18k | $71k |
| American Century Companies | Sep 2023 | 15k | $59k |
| Susquehanna International | Sep 2023 | 13k | $49k |
| Jane Street | Dec 2023 | 10k | $75k |
| Two Sigma Securities | Dec 2023 | 10k | $74k |
| Cutler | Dec 2023 | 2.5k | $0 |